OurCrowd (Investment in Syque Medical) LP — Form D
OurCrowd (Investment in Syque Medical) LP of JERUSALEM, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2018-12-12. $1.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2018-12-12
- Form: D
- Accession: 0001465818-18-000080
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Amount sold: $1.4M
- Minimum investment: $10K
- Investors: 62
- Date of first sale: 2018-11-28
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-327683
Issuer
- Name: OurCrowd (Investment in Syque Medical) LP
- CIK: 0001658178
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2015
- Address: 28 DERECH HEBRON, JERUSALEM, L3, 9108001
- Phone: 972-2-636-9300
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Steven Blumgart | Director | Jerusalem, L3 |
| Jonathan Medved | Director | Jerusalem, L3 |
| Steven Blumgart | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Jay Kalish | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
Other filings by this issuer (1)
More